News Conference News ESC 2017 Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death Yael L. Maxwell September 01, 2017
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Daily News Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor L.A. McKeown July 26, 2017
News Daily News TAVR Use Triples in France, With Docs Treating Lower-Risk Patients Michael O'Riordan June 26, 2017
News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017
News Daily News Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions Michael O'Riordan June 06, 2017
News Conference News ACC 2017 Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery Michael O'Riordan March 19, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2017 Shelley Wood March 01, 2017
News Conference News CRT 2017 Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation Michael O'Riordan February 22, 2017
News Daily News Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve Michael O'Riordan February 09, 2017
News Daily News TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure Todd Neale February 06, 2017
News Daily News Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban Michael O'Riordan January 03, 2017